Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EN3270 titration in chronic non-malignant pain
NCT00485225Phase 2Completed
- Sponsor
- DURECT Corporation
- Start
- Jun 2007
- Primary completion
- Apr 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of sufentanil in chronic pain, sponsored by DURECT Corporation. Started Jun 2007; status: completed.
02
Drugs
sufentanil
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT00485225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00485225.